Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
BIOTECHNOLOGY EUROPE-CALIFORNIA
03.11.2008 Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
06.10.2008 Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
03.10.2008 Amgen Appoints Francois de Carbonnel to the Company's Board of Directors
30.09.2008 Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology
22.08.2008 FDA Approves NplateTM for Long-Term Treatment of Adult Chronic ITP
13.08.2008 Genentech Special Committee of Independent Directors Responds to Roche Proposal
16.04.2008 Amgen Announces Webcast of 2008 First Quarter Financial Results
15.04.2008 Amgen Presents Preclinical and Clinical Data from Oncology Programs
14.04.2008 Genentech and Biogen Idec Announce Top-Line Results from a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis
14.04.2008 Early Data on Amgen's Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types
03.03.2008 Genentech Announces March 14 Webcast of Investment Community Meeting
05.02.2008 ACADIA Pharmaceuticals Announces Presentation of Data on Pimavanserin Co-Therapy at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
